FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis

THURSDAY, Aug. 21, 2025 -- The U.S. Food and Drug Administration has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).

Papzimeos is a nonreplicating, adenoviral vector-based...